Insight

Aug 12, 2024, 09:21

Giuseppe Banna: RBC-based scores improving prognostic systems in metastatic RCC

Giuseppe Banna, Consultant Medical Oncologist at Portsmouth Hospitals University NHS Trust, recently shared a post on X about a recent paper published in Immunotherapy.

“A red blood cell-based score in the prognostication of patients with metastatic RCC of the Meet-URO 15 study”

Authors: Shobana Anpalakhan, Giuseppe Luigi Banna, Sara Elena Rebuzzi, Giulia Mazzaschi, Sebastiano Buti et al.

“The potential of RBC-based scores to improve prognostic systems in metastatic renal cell carcinoma. Identifying patients with better prognosis and exploring molecular correlates could refine treatment strategies.

A red blood cell-based score in the prognostication of patients with metastatic RCC of the Meet-URO 15 study: Immunotherapy: Vol 0, No 0 – Get Access.”

Source: Giuseppe Banna/X

More posts by Giuseppe Banna in OncoDaily.

cancer Giulia Mazzaschi Giuseppe Luigi Banna immunotherapy metastatic renal cell carcinoma OncoDaily Oncology Portsmouth Hospitals University NHS Trust RCC Sara Elena Rebuzzi Sebastiano Buti Shobana Anpalakhan Treatment Strategies

Dr. Richard Pazdur's 25 Year WAR on Cancer at the FDA!

China Anti-Cancer Association (CACA) and OncoDaily Announce Strategic Partnership to Advance Global Cancer Care

Donald Trump: Thrilled to announce Robert F. Kennedy Jr. as The United States Secretary of HHS

Overview of ASCO Breakthrough

Robert De Niro and Prostate Cancer: How He Went Against, How He Survived, and More

Special Coverage